🧬 Top 3 Biotech & Longevity News Stories
1. World’s First Longevity Gene Therapy Enters Phase 1 Human Trial
Rejuvenate Bio has dosed the first human participant in a Phase 1 trial of a gene therapy targeting TERT — the gene encoding telomerase reverse transcriptase, the enzyme that maintains telomere length. The therapy uses an AAV9 vector to deliver a modified TERT gene. This is the first human trial explicitly designed to slow biological aging rather than treat a specific disease.
Source: STAT News · March 28, 2026
2. Updated Cholesterol Guidelines: Prevention Starts in Childhood
The American Heart Association and American College of Cardiology have released updated cholesterol guidelines that recommend statin therapy consideration beginning at age 10 for high-risk individuals — a fundamental shift from treating disease to preventing it across a lifetime. The guidelines also lower the LDL threshold for intervention from 190 to 160 mg/dL.
Source: PR Newswire · March 28, 2026
3. Altos Labs Publishes First Human Cell Reprogramming Data
Altos Labs has published its first peer-reviewed data showing successful partial reprogramming of human cells using a modified Yamanaka factor protocol. The cells showed a 40% reduction in epigenetic age markers without losing cell identity — addressing the tumor risk that plagued earlier Yamanaka factor research.
Source: Nature Aging · March 28, 2026
🚀 Top 3 Biotech & Longevity Product Releases
Focusing on tools and therapies that build towards a longer, healthier human future.
1. IBM/Roche Blood Sugar Prediction App — 72-Hour Glucose Forecasting
A joint IBM Research and Roche product uses continuous glucose monitor data combined with a machine learning model to predict blood sugar levels 72 hours in advance with 91% accuracy. The app is available on prescription in the EU and is pending FDA clearance. For the 537 million people living with diabetes globally, this is a meaningful quality-of-life shift.
Source: IBM Research · March 28, 2026
2. Levels Health Metabolic Score 2.0 — Whole-Body Metabolic Intelligence
Levels Health’s Metabolic Score 2.0 integrates CGM data, sleep, HRV, and activity into a single daily score with specific dietary and behavioral recommendations. The new version adds a “longevity trajectory” feature that projects metabolic age based on current trends.
Source: Levels Health · March 28, 2026
3. Fountain Life Longevity Panel — Full-Body Diagnostic
Fountain Life’s new longevity panel combines whole-genome sequencing, epigenetic age testing, advanced cardiac imaging, and cancer liquid biopsy into a single annual diagnostic. The panel is now available at 12 U.S. locations for $4,500 — down from $25,000 at launch in 2022.
Source: Fountain Life · March 28, 2026
🔬 Top 2 Biotech & Longevity Research Papers
1. Senolytics Extend Healthspan in Primates
Paper: “Senolytic Therapy Extends Healthspan and Reduces Age-Related Pathology in Non-Human Primates” (Cell)
The first primate study of senolytic drugs (dasatinib + quercetin) shows a 23% improvement in physical function and a 31% reduction in inflammatory markers in aged macaques over a 24-month treatment period. The study is the strongest preclinical evidence yet for senolytics in humans.
Source: Cell · March 2026
2. Gut Microbiome and Cognitive Aging
Paper: “Longitudinal Gut Microbiome Composition Predicts Cognitive Decline Rate in Adults Over 60” (Nature Medicine)
A 10-year longitudinal study of 4,200 adults over 60 finds that gut microbiome composition at baseline predicts cognitive decline rate with 78% accuracy — stronger than any single genetic or lifestyle factor studied. Three specific bacterial species are identified as protective: Akkermansia muciniphila, Bifidobacterium longum, and Faecalibacterium prausnitzii.
Source: Nature Medicine · March 2026
References
[1] World’s First Longevity Gene Therapy Targeting TERT Enters Phase 1 Human Trial [2] Updated Cholesterol Guideline Shifts Focus to Lifelong Prevention Starting in Childhood [3] Altos Labs Publishes First Human Cell Reprogramming Data in Nature Aging [4] IBM and Roche Launch 72-Hour Blood Sugar Prediction App Using CGM Data [5] Levels Health Metabolic Score 2.0: Longevity Trajectory Feature Added [6] Fountain Life Longevity Panel Now Available at 12 U.S. Locations [7] Senolytic Therapy Extends Healthspan and Reduces Age-Related Pathology in Non-Human Primates [8] Longitudinal Gut Microbiome Composition Predicts Cognitive Decline Rate in Adults Over 60
The Teknologist — Technology converging to make humanity better.